1-7 of 7
Richard Wilson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer

Manuela Salvucci, Maximilian L. Würstle, Clare Morgan, Sarah Curry, Mattia Cremona, Andreas U. Lindner, Orna Bacon, Alexa J. Resler, Áine C. Murphy, Robert O'Byrne, Lorna Flanagan, Sonali Dasgupta, Nadege Rice, Camilla Pilati, Elisabeth Zink, Lisa M. Schöller, Sinead Toomey, Mark Lawler, Patrick G. Johnston, Richard Wilson, Sophie Camilleri-Broët, Manuel Salto-Tellez, Deborah A. McNamara, Elaine W. Kay, Pierre Laurent-Puig, Sandra Van Schaeybroeck, Bryan T. Hennessy, Daniel B. Longley, Markus Rehm, Jochen H.M. Prehn
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (5): 1200–1212.
https://doi.org/10.1158/1078-0432.CCR-16-1084
Published: 28 February 2017
View article titled, A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer
Open the PDF for A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies

David Olmos, Douglas Barker, Rohini Sharma, Andre T. Brunetto, Timothy A. Yap, Anne B. Taegtmeyer, Jorge Barriuso, Hanine Medani, Yan Y. Degenhardt, Alicia J. Allred, Deborah A. Smith, Sharon C. Murray, Thomas A. Lampkin, Mohammed M. Dar, Richard Wilson, Johann S. de Bono, Sarah P. Blagden
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (10): 3420–3430.
https://doi.org/10.1158/1078-0432.CCR-10-2946
Published: 15 May 2011
View article titled, Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies
Open the PDF for Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies in another window
Includes: Supplementary data
Journal Articles

Prognostic Significance of TRAIL Signaling Molecules in Stage II and III Colorectal Cancer

Donal P. McLornan, Helen L. Barrett, Robert Cummins, Ultan McDermott, Cliona McDowell, Susie J. Conlon, Victoria M. Coyle, Sandra Van Schaeybroeck, Richard Wilson, Elaine W. Kay, Daniel B. Longley, Patrick G. Johnston
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (13): 3442–3451.
https://doi.org/10.1158/1078-0432.CCR-10-0052
Published: 30 June 2010
View article titled, Prognostic Significance of TRAIL Signaling Molecules in Stage II and III Colorectal Cancer
Open the PDF for Prognostic Significance of TRAIL Signaling Molecules in Stage II and III Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine

Jame Abraham, Maureen Edgerly, Richard Wilson, Clara Chen, Ann Rutt, Susan Bakke, Rob Robey, Andrew Dwyer, Barry Goldspiel, Frank Balis, Olaf Van Tellingen, Susan E. Bates, Tito Fojo
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (10): 3574–3582.
https://doi.org/10.1158/1078-0432.CCR-08-0938
Published: 18 May 2009
View article titled, A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine
Open the PDF for A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine in another window
Includes: Supplementary data
Journal Articles

Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors

Ruth Plummer, Christopher Jones, Mark Middleton, Richard Wilson, Jeffrey Evans, Anna Olsen, Nicola Curtin, Alan Boddy, Peter McHugh, David Newell, Adrian Harris, Patrick Johnson, Heidi Steinfeldt, Raz Dewji, Diane Wang, Lesley Robson, Hilary Calvert
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (23): 7917–7923.
https://doi.org/10.1158/1078-0432.CCR-08-1223
Published: 01 December 2008
View article titled, Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors
Open the PDF for Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors in another window
Journal Articles

Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01

Andrew B. Lassman, Michael R. Rossi, Jeffrey R. Razier, Lauren E. Abrey, Frank S. Lieberman, Chelsea N. Grefe, Kathleen Lamborn, William Pao, Alan H. Shih, John G. Kuhn, Richard Wilson, Norma J. Nowak, John K. Cowell, Lisa M. DeAngelis, Patrick Wen, Mark R. Gilbert, Susan Chang, W.A. Yung, Michael Prados, Eric C. Holland
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (21): 7841–7850.
https://doi.org/10.1158/1078-0432.CCR-05-0421
Published: 08 November 2005
View article titled, Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01
Open the PDF for Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01 in another window
Includes: Supplementary data
Journal Articles

The Roles of Thymidylate Synthase and p53 in Regulating Fas-Mediated Apoptosis in Response to Antimetabolites

Daniel Broderick Longley, Wendy Louise Allen, Ultan McDermott, Timothy Richard Wilson, Tariq Latif, John Boyer, Maria Lynch, Patrick Gerard Johnston
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (10): 3562–3571.
https://doi.org/10.1158/1078-0432.CCR-03-0532
Published: 24 May 2004
View article titled, The Roles of Thymidylate Synthase and p53 in Regulating Fas-Mediated Apoptosis in Response to Antimetabolites
Open the PDF for The Roles of Thymidylate Synthase and p53 in Regulating Fas-Mediated Apoptosis in Response to Antimetabolites in another window